Most patients with coronary arteriosclerosis have stable ischemic heart disease [1] and, in accord with 2002 Chronic Stable Angina Guideline and 2007 Focused Update of the American College of Cardiology (ACC)/American Heart Association (AHA) 2002 Guideline for the Management of Patients With Chronic Stable Angina, should be treated with OMT including anti-platelet agents, beta-adrenergic antagonists, ACE inhibitors or ARBs, and statins [2,3]. Here, ACE is linked to coronary artery disorder.